Form 4 for CME CME Group
Accepted 2026-09-17 16:23:52 ET · period of report 2026-09-15 · accession 0002153052-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 16:23 | 2026-09-15 | CME | Marchese John Clifford | GC, Sr MD | A - Grant | $275.09 | +784 | 3,839 | +26% | +$215.7K | |
| M | 2026-09-17 16:23 | 2026-09-15+ | CME | Marchese John Clifford | GC, Sr MD | F - Tax | $274.61 | -241 | 3,598 | -6% | -$66.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock Class A | 2026-09-15 | A | A | 784 | $275.09 | 3,839 | D | — | — | (F1) Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. This grant was determined based on the Reporting Person's role as of September 1, 2026 and prior to the effective date of his promotion to Senior Managing Director and General Counsel on September 11, 2026. Under CME Group's compensation program, the Reporting Person is entitled to a promotion-related equity grant in March 2027, which would be reported on a subsequent Form 4. |
| 2 | Common | Common Stock Class A | 2026-09-15 | F | D | 43 | $275.09 | 3,796 | D | — | — | (F2) Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. |
| 3 | Common | Common Stock Class A | 2026-09-15 | F | D | 47 | $275.09 | 3,749 | D | — | — | (F2) Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. |
| 4 | Common | Common Stock Class A | 2026-09-15 | F | D | 57 | $275.09 | 3,692 | D | — | — | (F2) Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. |
| 5 | Common | Common Stock Class A | 2026-09-15 | F | D | 50 | $275.09 | 3,642 | D | — | — | (F2) Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. |
| 6 | Common | Common Stock Class A | 2026-09-16 | F | D | 44 | $272.46 | 3,598 | D | — | — | (F2) Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. |